Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FTKPW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 13, 2025, for the supply of Nucala 100 mg/ml auto-injectors. The delivery order, valued at $3,785.80 with a firm fixed-price contract type, is set to be completed by August 14, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. This award was issued without a set-aside designation, demonstrating the company's competitive standing in federal pharmaceutical procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a broad range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and specialty items such as auto-injectors to support medical supply needs across Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a demonstrated portfolio of delivery orders covering diverse medical products from vaccines to oncology treatments and specialty injections.
Quick answers
Who was awarded contract SPE2DB25FTKPW?
SPE2DB25FTKPW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FTKPW worth?
The government has obligated $3,786 on SPE2DB25FTKPW.
Is contract SPE2DB25FTKPW an order under another contract?
Yes. SPE2DB25FTKPW is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKPW competed?
The extent of competition for SPE2DB25FTKPW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award